Shows decreased 6-TGN levels in pregnant women with inflammatory bowel disease, indicating no negative impacts on health outcomes.
Although 6-TGN levels decreased during pregnancy, these fluctuations were not associated with increased disease activity or toxicity. No significant increase in 6-MMPR levels was observed. Proactive monitoring may therefore not be warranted in the pregnant population.
No takes yet. Share an insight, caveat, or question.
Bouwknegt et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: